SS Innovations International Inc. (NASDAQ: SSII) announced record first-quarter 2026 financial results, with revenue surging 116.8% year over year to $11.1 million, fueled by growing adoption of its SSi Mantra surgical robotic system. The company reported an installed base of 194 SSi Mantra systems across 11 countries, with nearly 9,750 cumulative robotic procedures completed. Gross profit rose to $5.3 million, compared to $1.1 million in the same period last year, reflecting increased system installations and procedure volumes.
The company expanded its international market access during the quarter, receiving regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines. These approvals enable SS Innovations to tap into emerging healthcare markets where demand for advanced surgical technologies is rising. The company continues to pursue regulatory clearance in both the United States and Europe, which represent significant growth opportunities.
In a demonstration of its technological capabilities, SS Innovations recently completed the world's longest-distance robotic cardiac telesurgery, highlighting the potential of its remote surgery platform to broaden access to specialized surgical care. As of June 22, 2026, the cumulative number of multi-specialty procedures performed with the SSi Mantra system reached 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used for over 170 different types of procedures.
The strong quarterly performance underscores the accelerating commercial adoption of the SSi Mantra platform. The company's focus on expanding its presence in emerging markets, combined with its pursuit of U.S. and European regulatory approvals, positions it for continued growth. The successful telesurgery demonstration also signals potential for expanding surgical access in underserved regions.
For more information, visit the company's website at www.SSInnovations.com. InvestorWire, a platform providing press release syndication and corporate communications solutions, distributed the announcement. Details on terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
